Entecavir Monotherapy Suffices in Many Cases of Chronic Hepatitis B

Dr. Lok reported that she is an adviser or reviewer for Bristol-Myers Squibb, Gilead, Merck, Roche, Abbott, Bayer, and GlaxoSmithKline, and that she receives research or grant support from Bristol-Myers Squibb, Gilead, Merck, Roche, and GlaxoSmithKline.